Your session is about to expire
← Back to Search
Enhanced Quitline Support for Smoking Cessation (CONNECT Trial)
N/A
Waitlist Available
Led By Steffani Bailey
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up years 1-4
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether an online referral system for quitting smoking, with extra support to doctors, will help patients in community health centers quit smoking.
Who is the study for?
This trial is for adult tobacco users (18+) who have visited eligible study clinics in Oregon during a 24-month period. Participants must be willing to recruit a clinic champion and manager, agree to randomization, and their clinic should use the OCHIN Epic EHR system for at least one year.
What is being tested?
The trial tests an electronic Quitline referral system with enhanced academic detailing to see if it helps more people quit smoking. It compares how effective this strategy is against usual care in community health centers, also looking into its cost-effectiveness.
What are the potential side effects?
Since this trial involves informational interventions rather than medications or medical procedures, traditional side effects are not expected. However, participants may experience stress or discomfort related to quitting smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ years 1-4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~years 1-4
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Accepted electronic (e)Referral to Quitline
Secondary study objectives
Annual intervention costs
Cost-effectiveness
Incremental cost-effectiveness ratio
+5 moreOther study objectives
Tobacco use assessed
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ARM II (Quitline eReferral plus enhanced AD)Experimental Treatment2 Interventions
Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.
Group II: Arm I (Quitline eReferral)Active Control1 Intervention
Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityOTHER
1,006 Previous Clinical Trials
7,403,972 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,924 Previous Clinical Trials
41,007,951 Total Patients Enrolled
OHSU Knight Cancer InstituteLead Sponsor
236 Previous Clinical Trials
2,079,580 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to be assigned randomly to a treatment or comparison group in the study.I am 18 years old or older.You are willing to be randomly assigned to either the treatment group or the control group.You need to have a healthcare provider willing to share feedback and participate in training sessions, and a manager to coordinate the sessions.I am 18 years old or older.You have been identified as a current smoker during at least one visit to the study clinic within the past two years.You have been using the OCHIN Epic electronic health record system for at least one year.The study is only available to participants in Oregon.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (Quitline eReferral)
- Group 2: ARM II (Quitline eReferral plus enhanced AD)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger